Related Experiment Video
Updated: Aug 18, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Use of failure mode and effects analysis in improving the safety of i.v. drug administration
1Good Samaritan Hospital, San Jose, CA, USA.
Purpose:
Failure mode and effects analysis (FMEA) was used to identify dosing and administration errors associated with i.v. medications and evaluate the effectiveness of subsequent system improvements.
Summary:
A multidisciplinary medication safety team conducted an FMEA to identify and reduce common medication errors and selected wrong-dose errors for process improvement. In 2002, wrong-dose errors comprised 17% of all medication errors at the hospital (59 of 347 errors). The most common reason for administering the wrong dose was error in programming the i.v. infusion pump (41%). Potential errors (i.e., failures) identified were misinterpretation of the order, removing the wrong medication or wrong concentration of the correct medication, using the wrong diluent or drug to prepare the drip, and entering the wrong concentration or infusion rate on the pump. Errors in programming the i.v. infusion pump was the step in the medication-use process associated with the highest criticality index. Based on the results of the FMEA, two main interventions were performed. First, standard order sets were revised after streamlining the formulary and eliminating the use of unapproved abbreviations. Second, an i.v. pump with enhanced safety features was implemented. One-year follow-up data revealed that the number of medication errors related to dosing (wrong dose or incorrect infusion rate) had decreased slightly (from 59 in 2002 to 46 in 2003); however, a dramatic reduction was noted in the percentage of pump-related errors. In 2003, pump-related errors accounted for 22% of dosing errors, compared with 41% in 2002.
Conclusion:
Medication errors related to i.v. infusion pumps were reduced by conducting an FMEA and implementing the process changes needed.
Insights
Failure mode and effects analysis (FMEA) reduced intravenous medication errors. Implementing system improvements, including revised order sets and advanced infusion pumps, significantly decreased programming errors.
Area of Science:
- Healthcare quality improvement
- Patient safety research
- Clinical pharmacy practice
Background:
- Medication errors, particularly dosing and administration errors with intravenous (i.v.) medications, pose a significant risk to patient safety.
- Wrong-dose errors constituted 17% of all medication errors in 2002, with i.v. infusion pump programming errors being the most frequent cause (41%).
Purpose of the Study:
- To utilize Failure Mode and Effects Analysis (FMEA) to identify potential dosing and administration errors associated with i.v. medications.
- To evaluate the effectiveness of system improvements implemented to reduce these medication errors.
Main Methods:
- A multidisciplinary medication safety team conducted an FMEA to pinpoint critical failure points in the i.v. medication administration process.
- Interventions included revising standard i.v. order sets and implementing i.v. infusion pumps with enhanced safety features.
Main Results:
- The FMEA identified several potential errors, including misinterpretation of orders and incorrect programming of i.v. infusion pumps, with pump programming identified as having the highest criticality index.
- Following interventions, overall dosing errors decreased slightly, but pump-related errors saw a significant reduction from 41% in 2002 to 22% in 2003.
Conclusions:
- Conducting an FMEA is an effective strategy for identifying and mitigating medication errors related to i.v. infusion pumps.
- System-level changes, such as improved order sets and advanced technology, can substantially enhance medication safety and reduce administration errors.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Drug Regulation
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
One-Compartment Model: IV Infusion
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
